|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Lacosamide
Test Code16262
CPT Codes
80235
Preferred Specimen
2 mL serum collected in a red-top tube (no gel)
Minimum Volume
1 mL
Other Acceptable Specimens
Plasma collected in: EDTA (lavender-top) tube, or sodium heparin (green-top) tube
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Serum Separator Tube (SST®)
Methodology
Chromatography/Mass Spectrometry
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Tues-Sat; Report available: 2-4 days
Reference Range
Expected concentrations of Lacosamide in patients receiving recommended daily dosages: Up to 15.0 mcg/mL.
Toxic range not established.
Toxic range not established.
Clinical Significance
Lacosamide is an antiepileptic medication. Monitoring the serum concentration is beneficial to ensure compliance with drug therapy.